ISSN: 2167-065X

Clinical Pharmacology & Biopharmaceutics
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Editorial   
  • Clin Pharmacol Biopharm 2023, Vol 12(7): 353
  • DOI: 10.4172/2167-065X.1000353

Advances in Drug Delivery: Enhancing Therapeutic Efficacy through Targeted Approaches

Krizan Molloy*
Coconut Processing Research Division, Coconut Research Institute, Lunuwila, Sri Lanka
*Corresponding Author : Krizan Molloy, Coconut Processing Research Division, Coconut Research Institute, Lunuwila, Sri Lanka, Email: Krizan.molloy22@gmail.com

Received Date: Jul 03, 2023 / Published Date: Jul 28, 2023

Abstract

The field of pharmaceutical sciences has witnessed significant advancements in recent years, particularly in the area of targeted drug delivery systems. Traditional drug delivery methods often suffer from limitations such as low drug bioavailability, systemic toxicity, and lack of specificity, leading to suboptimal therapeutic outcomes and increased side effects. However, the emergence of targeted drug delivery systems has revolutionized the pharmaceutical industry by offering enhanced drug delivery capabilities, improved therapeutic efficacy, and reduced side effects. This article provides an overview of the latest advancements in targeted drug delivery systems and their potential applications in various disease conditions.

Citation: Molloy K (2023) Advances in Drug Delivery: Enhancing Therapeutic Efficacy through Targeted Approaches. Clin Pharmacol Biopharm, 12: 353. Doi: 10.4172/2167-065X.1000353

Copyright: © 2023 Molloy K. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Top